e-learning
resources
Munich 2014
Monday, 08.09.2014
Airways: reversibility and responsiveness
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects
V. Das, K. Pyasi, J. Londhe, A. Bhome, T. Sethi, A. Agrawal, S. Salvi, R. Kodgule, B. Brashier (Pune, New Delhi, India)
Source:
International Congress 2014 – Airways: reversibility and responsiveness
Session:
Airways: reversibility and responsiveness
Session type:
Poster Discussion
Number:
1824
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Das, K. Pyasi, J. Londhe, A. Bhome, T. Sethi, A. Agrawal, S. Salvi, R. Kodgule, B. Brashier (Pune, New Delhi, India). Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects. Eur Respir J 2014; 44: Suppl. 58, 1824
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Body-plethysmographic measurements of bronchodilator response in stable COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
Heterogeneity inside group D COPD patients: About 827 cases
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Airflow reversibility on long term outcomes of patients with COPD
Source: International Congress 2014 – Airways: reversibility and responsiveness
Year: 2014
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients
Source: International Congress 2016 – Monitoring airway diseases with different tools
Year: 2016
Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Annual FEV1 change : Post tuberculosis obstructive airway disease versus COPD
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016
Do all COPD patients present irreversible airflow limitation?
Source: Annual Congress 2013 –Expiration, exhalation and exhaustion: measures of dynamic volumes, breath analysis and respiratory muscles
Year: 2013
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Change in lung functions in patients with COPD during 6MWT
Source: Annual Congress 2013 –Clinical exercise physiology
Year: 2013
High rate of obstructive pulmonary function tests in adults below 40 Years of age in Germany
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014
Severity classification of DSP in COPD
Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Year: 2013
Telespirometry performed by general practitioners for early diagnosis of obstructive airway disease: Our experience
Source: International Congress 2014 – Respiratory function: quality and new technologies
Year: 2014
Scintigraphic parameters in COPD patients
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Clinical differences between emphysematous and non-emphysematous COPD
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI)
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016
Severity of airflow obstruction using NHANESIII versus ERS/GLI12 prediction equations in Caucasian American pulmonary laboratory patients
Source: International Congress 2014 – The impact of the Global Lung Initiative (GLI) reference equations and spirometry quality in all ages
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept